Individuals Coming Off Weight-Loss Medications Put On Weight Far More Rapidly Than People Using Diet and Exercise

Fresh analysis indicates that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain lost weight far faster than those who halt traditional diet and exercise plans.

Research printed in a leading health publication points out that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Users using these treatments must be cognizant of the danger of quick weight regain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to original mass in about a year and a half.

Comparing Treatments

The analysis, which examined 37 of trials involving over 9,000 of patients, compared the results of the injectable medications with other pills.

The team note that people who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Quick Rebound

Nutrition scientists propose the mechanism of the drugs is key to understanding the accelerated regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.

"Long-term administration of GLP-1 concentrations several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this medication results in appetite is unsuppressed, making excessive eating a significant risk."

A Lifelong Condition?

The NHS suggest the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts contend that, considering the high risk of relapse, the treatment should be considered ongoing.

This opinion is reinforced by pharmaceutical companies, who say that the results "highlight the long-term character of excess weight," comparing it to managing diseases like high blood pressure.

User Experiences

Users who have come off the jabs report a intense resurgence of hunger.

"It felt as if a trigger flipping and you're instantly extremely hungry," said a patient.

This difficulty is worsened if patients have not established lasting lifestyle or habit changes during treatment.

Widespread Use

Figures show that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Adoption is higher among women compared to men.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, experts stress that while these medications are potent tools for weight loss, they are not a permanent fix and lasting health benefits hinges on integrated lifestyle support.